BIOS logo

BioPlus Acquisition (BIOS) Cash From Operations

Annual CFO

-$691.50 K
NaN%

December 31, 2022

Summary

Performance

1-Year Change

-

3-Year Change

-101.75%

5-Year Change

+9.37%

15-Year Change

+9.37%

BIOS Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$127.39 M
BIOS annual cash flow from operations is currently -100.54% below its historical high of $127.39 million

3-Year Low

-$691.50 K
BIOS annual cash flow from operations is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
BIOS previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
BIOS next annual earnings announcement has not yet been scheduled

OtherBIOScash flowmetrics:

Annual CFI

$0.00
BIOS annual cash flow from investing activities is $0.00

Annual CFF

$196.20 K
BIOS annual cash flow from financing activities is $196.20 thousand

Annual FCF

-$691.50 K
BIOS annual free cash flow is -$691.50 thousand

Annual CAPEX

-
BIOS annual capital expenditures value is unknown

Quarterly CFO

-$878.90 K
-$563.30 K-178.49%

June 30, 2023

Summary

Performance

3-Month Change

-178.49%

1-Year Change

-722.17%

3-Year Change

-102.51%

5-Year Change

+94.19%

BIOS Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$48.34 M
BIOS quarterly cash flow from operations is currently -101.82% below its historical high of $48.34 million

3-Year Low

-$878.90 K
BIOS quarterly cash flow from operations is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2023
BIOS previous earnings announcement was published on Jun 30, 2023

Next Quarterly Earnings Report Date

N/A
BIOS next earnings announcement has not yet been scheduled

OtherBIOScash flowmetrics:

Quarterly CFI

$104.46 M
BIOS quarterly cash flow from investing activities is $104.46 million

Quarterly CFF

-$103.61 M
BIOS quarterly cash flow from financing activities is -$103.61 million

Quarterly FCF

-$878.90 K
BIOS quarterly free cash flow is -$878.90 thousand

Quarterly CAPEX

-
BIOS quarterly capital expenditures value is unknown

TTM CFO

-$1.61 M
-$772.00 K-91.84%

June 30, 2023

Summary

Performance

3-Month Change

-91.84%

1-Year Change

-489.83%

3-Year Change

-101.67%

5-Year Change

-104.09%

BIOS TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$127.39 M
BIOS TTM cash flow from operations is currently -101.27% below its historical high of $127.39 million

3-Year Low

-$1.61 M
BIOS TTM cash flow from operations is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2023
BIOS previous earnings announcement was published on Jun 30, 2023

Next Quarterly Earnings Report Date

N/A
BIOS next earnings announcement has not yet been scheduled

OtherBIOScash flowmetrics:

TTM CFI

$104.46 M
BIOS TTM cash flow from investing activities is $104.46 million

TTM CFF

-$103.14 M
BIOS TTM cash flow from financing activities is -$103.14 million

TTM FCF

-$1.61 M
BIOS TTM free cash flow is -$1.61 million

TTM CAPEX

-
BIOS TTM capital expenditures value is unknown

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

BIOS Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year--722.2%-489.8%
3 y3 years-101.8%-102.5%-101.7%
5 y5 years+9.4%+94.2%-104.1%

BIOS Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat low+722.2%at low+868.5%at low
5 y5-year-100.5%at low-101.8%at low-101.3%at low
alltimeall time-100.5%+9188.5%-101.8%+3659.5%-101.3%+4099.3%

BioPlus Acquisition Cash From Operations History

DateAnnualQuarterlyTTM
Jun 2023
-
-$878.90 K(+178.5%)
-$1.61 M(+91.8%)
Mar 2023
-
-$315.60 K(+36.9%)
-$840.60 K(+21.6%)
Dec 2022
-$691.50 K(-100.5%)
-$230.50 K(+22.9%)
-$691.50 K(+50.0%)
Sep 2022
-
-$187.60 K(+75.5%)
-$461.00 K(+68.6%)
Jun 2022
-
-$106.90 K(-35.8%)
-$273.40 K(+64.2%)
Mar 2022
-
-$166.50 K(-100.6%)
-$166.50 K(-100.1%)
Dec 2020
$127.39 M(+222.8%)
$25.66 M(-46.9%)
$127.39 M(+2.2%)
Sep 2020
-
$48.34 M(+38.2%)
$124.63 M(+28.8%)
Jun 2020
-
$34.99 M(+90.1%)
$96.78 M(+98.4%)
Mar 2020
-
$18.40 M(-19.6%)
$48.79 M(+23.6%)
Dec 2019
$39.47 M(+61.6%)
$22.90 M(+11.7%)
$39.47 M(-35.6%)
Sep 2019
-
$20.49 M(-257.6%)
$61.24 M(+50.0%)
Jun 2019
-
-$13.00 M(-243.2%)
$40.83 M(+5.5%)
Mar 2019
-
$9.08 M(-79.7%)
$38.70 M(+58.4%)
Dec 2018
$24.43 M(-3301.6%)
$44.67 M(>+9900.0%)
$24.43 M(-310.9%)
Sep 2018
-
$84.00 K(-100.6%)
-$11.58 M(-27.8%)
Jun 2018
-
-$15.13 M(+191.5%)
-$16.05 M(-416.1%)
Mar 2018
-
-$5.19 M(-160.0%)
$5.08 M(-765.5%)
Dec 2017
-$763.00 K(-98.2%)
$8.66 M(-297.4%)
-$763.00 K(-94.3%)
Sep 2017
-
-$4.39 M(-173.1%)
-$13.43 M(-48.3%)
Jun 2017
-
$6.00 M(-154.4%)
-$25.99 M(-39.0%)
Mar 2017
-
-$11.03 M(+175.6%)
-$42.61 M(+0.2%)
Dec 2016
-$42.54 M(-33.8%)
-$4.00 M(-76.4%)
-$42.54 M(+17.7%)
Sep 2016
-
-$16.95 M(+59.5%)
-$36.14 M(-8.9%)
Jun 2016
-
-$10.63 M(-3.1%)
-$39.66 M(-15.9%)
Mar 2016
-
-$10.96 M(-557.7%)
-$47.15 M(-26.6%)
Dec 2015
-$64.23 M(+104.4%)
$2.40 M(-111.7%)
-$64.23 M(-3.1%)
Sep 2015
-
-$20.46 M(+13.0%)
-$66.30 M(+42.3%)
Jun 2015
-
-$18.11 M(-35.4%)
-$46.60 M(+39.2%)
Mar 2015
-
-$28.05 M(-8624.9%)
-$33.48 M(+6.6%)
Dec 2014
-$31.42 M(-42.4%)
$329.00 K(-142.9%)
-$31.42 M(-34.6%)
Sep 2014
-
-$767.00 K(-84.6%)
-$48.06 M(-24.3%)
Jun 2014
-
-$4.99 M(-80.8%)
-$63.50 M(-6.2%)
Mar 2014
-
-$25.99 M(+59.2%)
-$67.72 M(+24.1%)
Dec 2013
-$54.58 M(-303.0%)
-$16.32 M(+0.7%)
-$54.58 M(+49.0%)
Sep 2013
-
-$16.20 M(+76.0%)
-$36.63 M(+117.9%)
Jun 2013
-
-$9.21 M(-28.3%)
-$16.81 M(-246.1%)
Mar 2013
-
-$12.85 M(-887.3%)
$11.51 M(-57.2%)
Dec 2012
$26.88 M(-0.3%)
$1.63 M(-54.8%)
$26.88 M(+109.9%)
Sep 2012
-
$3.61 M(-81.1%)
$12.81 M(+26.7%)
Jun 2012
-
$19.11 M(+657.0%)
$10.11 M(-567.8%)
Mar 2012
-
$2.52 M(-120.3%)
-$2.16 M(-108.0%)
Dec 2011
$26.97 M(-225.9%)
-$12.44 M(-1461.4%)
$26.97 M(+122.8%)
Sep 2011
-
$914.00 K(-86.6%)
$12.10 M(-68.0%)
Jun 2011
-
$6.84 M(-78.4%)
$37.84 M(+20.0%)
Mar 2011
-
$31.66 M(-215.9%)
$31.53 M(-247.2%)
Dec 2010
-$21.42 M(-194.2%)
-
-
Dec 2010
-
-$27.31 M(-202.5%)
-$21.42 M(-246.1%)
Sep 2010
-
$26.65 M(+4899.6%)
$14.66 M(-175.9%)
Jun 2010
-
$533.00 K(-102.5%)
-$19.32 M(+38.5%)
Mar 2010
-
-$21.29 M(-342.9%)
-$13.95 M(-161.3%)
Dec 2009
$22.75 M(-360.1%)
-
-
Dec 2009
-
$8.77 M(-219.6%)
$22.75 M(+10.3%)
Sep 2009
-
-$7.33 M(-224.2%)
$20.62 M(-504.8%)
Jun 2009
-
$5.90 M(-61.7%)
-$5.09 M(-126.6%)
Mar 2009
-
$15.41 M(+132.0%)
$19.13 M(-318.7%)
Dec 2008
-$8.75 M
-
-
Dec 2008
-
$6.64 M(-120.1%)
-$8.75 M(-18.0%)
DateAnnualQuarterlyTTM
Sep 2008
-
-$33.04 M(-209.7%)
-$10.67 M(-136.3%)
Jun 2008
-
$30.12 M(-341.6%)
$29.36 M(+257.2%)
Mar 2008
-
-$12.47 M(-364.2%)
$8.22 M(-66.0%)
Dec 2007
$24.19 M(-181.0%)
-
-
Dec 2007
-
$4.72 M(-32.5%)
$24.19 M(+88.9%)
Sep 2007
-
$6.99 M(-22.2%)
$12.80 M(-345.0%)
Jun 2007
-
$8.98 M(+156.6%)
-$5.22 M(-74.5%)
Mar 2007
-
$3.50 M(-152.5%)
-$20.46 M(-31.5%)
Dec 2006
-$29.86 M(+365.0%)
-
-
Dec 2006
-
-$6.67 M(-39.6%)
-$29.86 M(+72.0%)
Sep 2006
-
-$11.04 M(+76.5%)
-$17.37 M(+69.3%)
Jun 2006
-
-$6.25 M(+6.0%)
-$10.26 M(+2.2%)
Mar 2006
-
-$5.90 M(-201.3%)
-$10.04 M(+56.3%)
Dec 2005
-$6.42 M(-295.0%)
-
-
Dec 2005
-
$5.83 M(-248.3%)
-$6.42 M(-34.8%)
Sep 2005
-
-$3.93 M(-34.9%)
-$9.85 M(+343.0%)
Jun 2005
-
-$6.03 M(+163.8%)
-$2.22 M(-128.3%)
Mar 2005
-
-$2.29 M(-195.3%)
$7.85 M(+138.3%)
Dec 2004
$3.29 M(-77.0%)
-
-
Dec 2004
-
$2.40 M(-35.1%)
$3.29 M(-58.5%)
Sep 2004
-
$3.70 M(-8.4%)
$7.95 M(+484.6%)
Jun 2004
-
$4.04 M(-159.0%)
$1.36 M(-31.6%)
Mar 2004
-
-$6.84 M(-197.0%)
$1.99 M(-86.1%)
Dec 2003
$14.34 M(-31.0%)
-
-
Dec 2003
-
$7.05 M(-344.1%)
$14.34 M(+45.2%)
Sep 2003
-
-$2.89 M(-161.9%)
$9.88 M(-46.3%)
Jun 2003
-
$4.67 M(-15.4%)
$18.38 M(+37.3%)
Mar 2003
-
$5.51 M(+113.5%)
$13.38 M(-35.7%)
Dec 2002
$20.80 M(+90.4%)
-
-
Dec 2002
-
$2.58 M(-54.0%)
$20.80 M(-21.7%)
Sep 2002
-
$5.61 M(-1826.8%)
$26.58 M(+38.1%)
Jun 2002
-
-$325.00 K(-102.5%)
$19.25 M(-3.6%)
Mar 2002
-
$12.93 M(+54.7%)
$19.98 M(+82.8%)
Dec 2001
$10.93 M(-3.6%)
-
-
Dec 2001
-
$8.36 M(-586.1%)
$10.93 M(+6.3%)
Sep 2001
-
-$1.72 M(-525.7%)
$10.28 M(+63.3%)
Jun 2001
-
$404.00 K(-89.6%)
$6.29 M(+8.8%)
Mar 2001
-
$3.88 M(-49.7%)
$5.79 M(-49.0%)
Dec 2000
$11.33 M(-12.1%)
-
-
Dec 2000
-
$7.71 M(-235.3%)
$11.33 M(+222.2%)
Sep 2000
-
-$5.70 M(+5330.5%)
$3.52 M(-80.1%)
Jun 2000
-
-$105.00 K(-101.1%)
$17.72 M(-14.5%)
Mar 2000
-
$9.43 M(-9166.3%)
$20.73 M(+60.7%)
Dec 1999
$12.90 M(-178.6%)
-
-
Dec 1999
-
-$104.00 K(-101.2%)
$12.90 M(-714.1%)
Sep 1999
-
$8.50 M(+193.1%)
-$2.10 M(-55.3%)
Jun 1999
-
$2.90 M(+81.3%)
-$4.70 M(-11.3%)
Mar 1999
-
$1.60 M(-110.6%)
-$5.30 M(-67.7%)
Dec 1998
-$16.40 M(+429.0%)
-
-
Dec 1998
-
-$15.10 M(-355.9%)
-$16.40 M(+1950.0%)
Sep 1998
-
$5.90 M(+156.5%)
-$800.00 K(-82.2%)
Jun 1998
-
$2.30 M(-124.2%)
-$4.50 M(-63.4%)
Mar 1998
-
-$9.50 M(-2000.0%)
-$12.30 M(+296.8%)
Dec 1997
-$3.10 M(-59.2%)
-
-
Dec 1997
-
$500.00 K(-77.3%)
-$3.10 M(-13.9%)
Sep 1997
-
$2.20 M(-140.0%)
-$3.60 M(-37.9%)
Jun 1997
-
-$5.50 M(+1733.3%)
-$5.80 M(+1833.3%)
Mar 1997
-
-$300.00 K
-$300.00 K
Dec 1996
-$7.60 M
-
-

FAQ

  • What is BioPlus Acquisition annual cash flow from operations?
  • What is the all time high annual CFO for BioPlus Acquisition?
  • What is BioPlus Acquisition quarterly cash flow from operations?
  • What is the all time high quarterly CFO for BioPlus Acquisition?
  • What is BioPlus Acquisition quarterly CFO year-on-year change?
  • What is BioPlus Acquisition TTM cash flow from operations?
  • What is the all time high TTM CFO for BioPlus Acquisition?
  • What is BioPlus Acquisition TTM CFO year-on-year change?

What is BioPlus Acquisition annual cash flow from operations?

The current annual CFO of BIOS is -$691.50 K

What is the all time high annual CFO for BioPlus Acquisition?

BioPlus Acquisition all-time high annual cash flow from operations is $127.39 M

What is BioPlus Acquisition quarterly cash flow from operations?

The current quarterly CFO of BIOS is -$878.90 K

What is the all time high quarterly CFO for BioPlus Acquisition?

BioPlus Acquisition all-time high quarterly cash flow from operations is $48.34 M

What is BioPlus Acquisition quarterly CFO year-on-year change?

Over the past year, BIOS quarterly cash flow from operations has changed by -$772.00 K (-722.17%)

What is BioPlus Acquisition TTM cash flow from operations?

The current TTM CFO of BIOS is -$1.61 M

What is the all time high TTM CFO for BioPlus Acquisition?

BioPlus Acquisition all-time high TTM cash flow from operations is $127.39 M

What is BioPlus Acquisition TTM CFO year-on-year change?

Over the past year, BIOS TTM cash flow from operations has changed by -$1.34 M (-489.83%)